BRIEF-Kura Oncology And Kyowa Kirin Announce Positive Ziftomenib Monotherapy Registrational Trial

Reuters
06 Feb
BRIEF-Kura Oncology And Kyowa Kirin Announce Positive Ziftomenib Monotherapy Registrational Trial

Feb 5 (Reuters) - Kyowa Kirin Co Ltd 4151.T:

  • KURA ONCOLOGY AND KYOWA KIRIN ANNOUNCE POSITIVE ZIFTOMENIB MONOTHERAPY REGISTRATIONAL TRIAL AND POSITIVE FDA FEEDBACK FOR UPCOMING FRONTLINE COMBINATION TRIAL DESIGNS

  • KURA ONCOLOGY INC: NDA SUBMISSION FOR ZIFTOMENIB ON TRACK FOR 2Q 2025

  • KURA ONCOLOGY INC: KOMET-017-IC AND NIC PHASE 3 TRIALS EXPECTED TO INITIATE IN 2H 2025

Source text: ID:nGNX4xK0s3

Further company coverage: 4151.T

((reuters.briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10